MK

Mikky Kumari

Active Director Director DIN 11197092
DIN 11197092 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mikky Kumari

Data last updated:

Mikky Kumari is a Director at Docnpill Pharmaceutical Private Limited (since 2025).

DIN 11197092
Primary Designation Director
First Appointment 16 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jul 20252025Active

Directorship timeline

Open interactive timeline →
Docnpill Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Mikky Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mikky Kumari

Mikky Kumari currently holds 1 directorship: Docnpill Pharmaceutical Private Limited (Director, since 16 Jul 2025).

Mikky Kumari was first appointed on 16 Jul 2025 as Director at Docnpill Pharmaceutical Private Limited.

The current boards of Mikky Kumari's companies include Arumainathan Vishnu (Docnpill Pharmaceutical Private Limited), Karthik Sheelvant (Docnpill Pharmaceutical Private Limited), Mani Roopa (Docnpill Pharmaceutical Private Limited), Sachin Reddy Krishnappa Muniraju Reddy (Docnpill Pharmaceutical Private Limited), Sheetal Kamat (Docnpill Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available